Please sign in to follow a disease.
Thromboangiitis obliterans
MONDO:0008889A rare inflammatory non-necrotizing vascular disease affecting the small- and medium-sized arteries and veins of the upper and lower extremities characterized by endarteritis and vaso-occlusion due to occlusive thrombus development. The development and progression of the disease is consistently associated with exposure to tobacco.
Also known as: Buerger's Disease, Buerger's disease, thromboangiitis obliterans, thromboangiitis obliterans [Buerger's disease], BUERGER disease, TAO, inflammatory occlusive peripheral vascular disease, occlusive peripheral vascular disease
9 clinical trials for this condition and its sub-types, 4 tagged with Thromboangiitis obliterans itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Stem cell shot aims to save limbs in rare artery disease
Disease control Recruiting nowThis study is testing whether injections of Stempeucel, a stem cell product made from donor bone marrow, can help people with critical limb ischemia caused by Buerger's disease. The goal is to see if it reduces pain, heals ulcers, improves blood flow, and prevents amputation. Onl…
Phase 4 • Sponsor: Cell Biopeutics Resources Sdn Bhd • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
New antibody shot could trap nicotine in smokers
Symptom relief Recruiting nowThis early-stage study tests a new drug called ATI-1013 in 15 healthy smokers. The drug is an antibody designed to bind to nicotine in the body. The main goal is to check safety and see how long the drug stays in the system. Participants get one IV dose of the drug or a placebo a…
Phase 1 • Sponsor: Antidote Therapeutics, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC